Cargando…

Skeletonized mean diffusivity and neuropsychological performance in relapsing‐remitting multiple sclerosis

BACKGROUND: Peak width of Skeletonized Mean Diffusivity (PSMD), as a novel marker of white matter (WM) microstructure damage, is associated with cognitive decline in several WM pathologies (i.e., small vessel disorders). We hypothesized that markers combining alterations in whole WM could be associa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chylińska, Magdalena, Karaszewski, Bartosz, Komendziński, Jakub, Wyszomirski, Adam, Sabisz, Agnieszka, Halas, Marek, Szurowska, Edyta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226842/ https://www.ncbi.nlm.nih.gov/pubmed/35560868 http://dx.doi.org/10.1002/brb3.2591

Ejemplares similares

The association between white matter tract structural connectivity and information processing speed in relapsing-remitting multiple sclerosis
por: Chylińska, Magdalena, et al.
Publicado: (2023)

Brain Atrophy as an Outcome of Disease-Modifying Therapy for Remitting-Relapsing Multiple Sclerosis
por: Chylińska, Magdalena, et al.
Publicado: (2023)

SWATH-MS for prospective identification of protein blood biomarkers of rtPA-associated intracranial hemorrhage in acute ischemic stroke: a pilot study
por: Karaszewski, Bartosz, et al.
Publicado: (2021)

New Remote Cerebral Microbleeds on T2(*)-Weighted Echo Planar MRI After Intravenous Thrombolysis for Acute Ischemic Stroke
por: Jabłoński, Bartosz, et al.
Publicado: (2022)

Understanding the Physiopathology Behind Axial and Radial Diffusivity Changes—What Do We Know?
por: Winklewski, Pawel J., et al.
Publicado: (2018)

Extended Interval Dosing Natalizumab and impact on neuropsychological deficits in Relapsing-Remitting Multiple Sclerosis
por: McManus, Eileen J., et al.
Publicado: (2022)

Efficacy and Safety of Intravenous rtPA in Ischemic Strokes Due to Small-Vessel Occlusion: Systematic Review and Meta-Analysis
por: Karaszewski, Bartosz, et al.
Publicado: (2021)

Associations of Peak-Width Skeletonized Mean Diffusivity and Post-Stroke Cognition
por: Jochems, Angela C. C., et al.
Publicado: (2022)

The Application of Diffusion Kurtosis Imaging on the Heterogeneous White Matter in Relapsing-Remitting Multiple Sclerosis
por: Zhu, Qiyuan, et al.
Publicado: (2022)

Imaging of Morphological Background in Selected Functional and Inflammatory Gastrointestinal Diseases in fMRI
por: Skrobisz, Katarzyna, et al.
Publicado: (2020)

Evaluation of Subcortical Structure Volumes in Patients with Non-Specific Digestive Diseases
por: Skrobisz, Katarzyna, et al.
Publicado: (2022)

Peak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular Damage
por: Low, Audrey, et al.
Publicado: (2020)

Postural Control in Relapsing-Remitting Multiple Sclerosis
por: Cusin, Flavia Salvaterra, et al.
Publicado: (2022)

Blood-brain barrier permeability and physical exercise
por: Małkiewicz, Marta A., et al.
Publicado: (2019)

Neuropsychological exponents for the driving ability in remitted bipolar patients
por: Joachimiak, Piotr, et al.
Publicado: (2022)

Balance Changes in Patients With Relapsing-Remitting Multiple Sclerosis: A Pilot Study Comparing the Dynamics of the Relapse and Remitting Phases
por: Findling, Oliver, et al.
Publicado: (2018)

Compensatory functional reorganization may precede hypertension-related brain damage and cognitive decline: a functional magnetic resonance imaging study
por: Naumczyk, Patrycja, et al.
Publicado: (2017)

Use of functional magnetic resonance imaging in patients with irritable bowel syndrome and functional dyspepsia
por: Skrobisz, Katarzyna, et al.
Publicado: (2019)

Aging and Hypertension – Independent or Intertwined White Matter Impairing Factors? Insights From the Quantitative Diffusion Tensor Imaging
por: Sabisz, Agnieszka, et al.
Publicado: (2019)

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
por: Tenorio-Laranga, Jofre, et al.
Publicado: (2010)

Varicella Zoster Virus and Relapsing Remitting Multiple Sclerosis
por: Sotelo, Julio, et al.
Publicado: (2011)

Disease-modifying therapies in relapsing–remitting multiple sclerosis
por: González-Andrade, Fabricio, et al.
Publicado: (2010)

Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
por: Chan, Andrew, et al.
Publicado: (2016)

An Overview of Therapeutic Options in Relapsing-remitting Multiple Sclerosis
por: Saleem, Sidra, et al.
Publicado: (2019)

Abnormal multisensory integration in relapsing–remitting multiple sclerosis
por: Giurgola, Serena, et al.
Publicado: (2022)

Character pathology and neuropsychological test performance in remitted opiate dependence
por: Prosser, James M, et al.
Publicado: (2008)

A novel tool for phase contrast MR-derived pulse wave velocity measurement - validation against applanation tonometry and phantom studies
por: Dorniak, Karolina, et al.
Publicado: (2015)

Comparison of Pharmacological Therapies in Relapse Rates in Patients With Relapsing-Remitting Multiple Sclerosis
por: Etta, Indu, et al.
Publicado: (2023)

Relapse recovery in relapsing–remitting multiple sclerosis: An analysis of the CombiRx dataset
por: Koch, Marcus W, et al.
Publicado: (2023)

Peak width of skeletonized mean diffusivity and cognitive performance in cerebral amyloid angiopathy
por: Horn, Mitchell J., et al.
Publicado: (2023)

Modern Technology in Multi-Shell Diffusion MRI Reveals Diffuse White Matter Changes in Young Adults With Relapsing-Remitting Multiple Sclerosis
por: Beaudoin, Ann-Marie, et al.
Publicado: (2021)

Natalizumab: A new treatment for relapsing remitting multiple sclerosis
por: Hutchinson, Michael
Publicado: (2007)

Alemtuzumab: evidence for its potential in relapsing—remitting multiple sclerosis
por: Brown, JWL, et al.
Publicado: (2013)

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
por: Romme Christensen, Jeppe, et al.
Publicado: (2012)

Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis
por: Lugaresi, Alessandra, et al.
Publicado: (2013)

Defective structural RNA processing in relapsing-remitting multiple sclerosis
por: Spurlock, Charles F, et al.
Publicado: (2015)

Thalamic–hippocampal–prefrontal disruption in relapsing–remitting multiple sclerosis
por: Kern, Kyle C., et al.
Publicado: (2014)

Natalizumab is Effective for the Treatment of Relapsing-remitting Tumefactive Multiple Sclerosis
por: Nakamura, Masataka, et al.
Publicado: (2017)

Sexual dysfunction in female patients with relapsing‐remitting multiple sclerosis
por: Bartnik, Pawel, et al.
Publicado: (2017)

Cerebellar Information Processing in Relapsing-Remitting Multiple Sclerosis (RRMS)
por: Lesage, E., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_pk4oei5m0l3oqblqtdat42mm47